Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology; D003331:Coronary Vessels; D004176:Dipyridamole / Q000494:pharmacology*; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D005263:Femoral Artery; D005268:Femoral Vein; D006614:Hindlimb; D006940:Hyperemia; D008297:Male; D009705:Nucleosides / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D009705:Nucleosides; D014665:Vasodilator Agents; D004176:Dipyridamole; D000109:Acetylcholine; D001920:Bradykinin